Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Part of paid clinical trials in La Jolla, California.

Sponsor
AIDS Malignancy Consortium
Study ID
NCT05510908
Status
Completed

Conditions

  • AIDS Related Lymphoma
  • AIDS-Related Malignancy
  • AIDS-related Kaposi Sarcoma
  • Anal Cancer
  • Cancer
  • HIV Infections
  • HIV-Associated Malignant Neoplasm
  • HPV-Related Malignancy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional — OTHER
    Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.
  • Non-Interventional Follow-up — OTHER
    Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.

Study Details

This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.

Key Dates

Start date
Jul 25, 2023
Status verified
Mar 2026
Primary completion
Feb 28, 2025
Completion
Jun 2, 2025

Study Design

Enrollment
460 participants (actual)

Arms

  • Arm: New, primary or recurrent disease
    Considering or currently receiving cancer treatment
  • Arm: Metastic or locally advanced cancer
    This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies.
  • Arm: Prior cancer
    Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy.

Primary Outcome Measure

Number of Cancers in People With HIV (PWH) Who Present for Care at Domestic AMC Sites [ Time Frame: Enrollment ]

Locations (15)

FacilityCityStateZIPSite coordinators
Moores UCSD Cancer CenterLa JollaCalifornia92903-
George Washington University Cancer CenterWashington D.C.District of Columbia20037-
University of Miami Miller School of Medicine-Sylvester Cancer CenterMiamiFlorida33136-
Moffitt Cancer CenterTampaFlorida33612-
University of Illinois at ChicagoChicagoIllinois60612-
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimoreMaryland21231-
Washington University School of MedicineSt LouisMissouri63110-
Mount Sinai HospitalNew YorkNew York10029-
Weill Cornell Medicine - Cornell Clinical Trials UnitNew YorkNew York10010-
Montefiore Medical CenterThe BronxNew York10467-
The Ohio State UniversityColumbusOhio43210-
Abramson Cancer Center at Pennsylvania HospitalPhiladelphiaPennsylvania19106-
MD Anderson Cancer CenterHoustonTexas77030-
Huntsman Cancer Institute - University of UtahSalt Lake CityUtah84112-
Virginia Mason Medical CenterSeattleWashington98101-

Find similar trials in La Jolla, CA

By condition
HIV
By specialty
Infectious disease
By research site
Moores UCSD Cancer Center· La Jolla, CAGeorge Washington University Cancer Center· Washington D.C., DCUniversity of Miami Miller School of Medicine-Sylvester Cancer Center· Miami, FLMoffitt Cancer Center· Tampa, FLUniversity of Illinois at Chicago· Chicago, ILSidney Kimmel Comprehensive Cancer Center at Johns Hopkins· Baltimore, MD

Related Studies